IGF-1 LR3: dosing, reconstitution and evidence
A modified IGF-1 analog with an arginine substitution and a 13-amino-acid extension that dramatically reduces binding-protein affinity — greatly increasing potency and duration versus native IGF-1.
Also known as Long R3 IGF-1
IGF-1 LR3 quick start
- Route
- SubQ
- Typical dose
- 20–50 mcg
- Frequency
- Daily
- Half-life
- Roughly 20–30 hours, versus about 10–20 minutes for native IGF-1.
- Cycle
- 4 weeks maximum is the commonly cited limit.
- Vial sizes sold
- 1mg or 5mg
How to run it
- How often
- Daily
- Cycle length
- 4 weeks maximum is the commonly cited limit.
- Half-life
- Roughly 20–30 hours, versus about 10–20 minutes for native IGF-1.
- Route
- SubQ
What people actually run
Established but respected — the community treats hypoglycemia risk seriously and keeps cycles short.
What to expect
Most people tolerate IGF-1 LR3 well. Here is what is worth knowing going in, so nothing catches you by surprise.
Known interactions
Interactions involving IGF-1 LR3's drug class that DoseIQ screens for. Each one cites where it comes from — an FDA label section or the published record — because an interaction warning you can't trace is just noise.
IGF-1 drives glucose into muscle on top of medication doing the same — this is the combination that puts people on the floor.
What to do: This pairing needs your prescriber's explicit awareness, glucose on hand, and monitoring.
Source: Community consensus + IGF-1 pharmacology; the Guru's straight-talk list
Reconstitution guide
IGF-1 LR3 ships as a lyophilised powder and gets mixed with bacteriostatic water before use. How much water you add sets the concentration, which sets how many syringe units make up each dose. One unit on a U-100 syringe is 0.01 mL — the tables below do the arithmetic for the vial sizes you are most likely to be holding.
1mg vial most common
| Water added | Concentration | 20mcg | 50mcg |
|---|---|---|---|
| 1mL (common) | 1 mg/mL | 0.02 mL 2 units | 0.05 mL 5 units |
| 2mL | 500 mcg/mL | 0.04 mL 4 units | 0.10 mL 10 units |
5mg vial
| Water added | Concentration | 20mcg | 50mcg |
|---|---|---|---|
| 1mL (common) | 5 mg/mL | 0.00 mL 0.4 units | 0.01 mL 1 units |
| 2mL | 2.5 mg/mL | 0.01 mL 0.8 units | 0.02 mL 2 units |
Standard steps
- Inspect the vialConfirm the label and that the powder cake is intact. Do not use a cracked or compromised vial.
- Let it reach room temperatureSitting out for a few minutes reduces condensation inside the vial when the seal is broken.
- Disinfect both stoppersWipe the compound vial and the bacteriostatic water vial with a fresh alcohol swab and let them air-dry.
- Draw the bacteriostatic waterUse a sterile syringe to draw the volume you have chosen from the reconstitution table.
- Add the water down the vial wallInject slowly so it runs down the inside wall rather than spraying directly onto the powder. This limits foaming.
- Dissolve gentlySwirl or roll the vial between your hands until the cake dissolves. Never shake — agitation damages peptide bonds. The solution should end up clear.
- Label and refrigerateWrite the reconstitution date and concentration on the vial. Store at 2–8°C. Do not freeze.
This page is an educational research reference and is not medical advice. IGF-1 LR3 is not approved for human use in any jurisdiction. Dose figures reflect the published record and what the community has converged on — starting points to weigh, not instructions. Consult a qualified healthcare provider before starting any protocol.